Blockchain Registration Transaction Record

Tiziana Life Sciences CEO Discusses Advancements in Neurodegenerative Disease Treatments

Tiziana Life Sciences CEO shares advancements in neurodegenerative disease treatments and secures $3.4 million in funding, demonstrating commitment to patient care and research.

Tiziana Life Sciences CEO Discusses Advancements in Neurodegenerative Disease Treatments

This news matters as Tiziana Life Sciences' advancements in neurodegenerative disease treatments, including MS and Alzheimer's, have the potential to significantly impact patient outcomes and offer hope for those suffering from these conditions. The company's progress in securing funding also demonstrates its commitment to advancing these important treatments.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x43f8167ac9d9a0abcb576e70e01c69a4e905f621fd53ce907fae72ddefad6677
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintgainSZ_t-88645bedb171f53c05a447e6191c99ae